ArticleJournal for immunotherapy of cancer2021

Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells.

Songbo Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.